Search Results
Mar 05, 2026, 12:59 ET Why Does Chronic Back Pain Make Everyday Sounds Feel Harsher? Brain Imaging Study Points to a Treatable Cause
amplification happening in the brain, and that opens the door for treatments that can help turn that volume down," said the paper's senior author Yoni Ashar, PhD, assistant professor of internal medicine and co-director of the
More news about: University of Colorado Anschutz
Mar 05, 2026, 12:25 ET Shared origins illuminate potential dependency across brain tumor types
Paul Northcott, PhD, St. Jude
More news about: St. Jude Children's Research Hospital
Mar 05, 2026, 10:15 ET KLDiscovery Names Julian Merschen as Chief Product Officer, Launches ECAi for AI-Driven Early Case Assessment
product, engineering, AI, and UX organizations applying machine learning and advanced analytics to complex, data-intensive environments. Merschen holds a PhD in Mathematics from the London School of Economics. His experience building enterprise-scale data platforms, AI-driven decision systems, and generative
More news about: KLDiscovery Inc.
Mar 05, 2026, 09:28 ET Smartria Appoints Clayton Webster, PhD as Head of AI and Engineering to Lead Next Phase of Innovation
Clayton Webster, PhD, as the firm's first Head of AI and Engineering. In this newly created role, Webster will lead Smartria's artificial intelligence (AI) strategy
More news about: Smartria
Mar 05, 2026, 09:28 ET Cerecin Announces TEDx Talk by CEO Dr. Charles Stacey is Now Available Online
on energy as a foundational driver of brain function," said Samuel Henderson, PhD, Chief Scientific Officer of Cerecin. Dr. Henderson, who has more than 20 years of experience in neurodegenerative disease research and a PhD in molecular genetics and cell biology from the University of Chicago, leads Cerecin's
More news about: Cerecin Inc.
Mar 05, 2026, 09:15 ET Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering
discovery and improve health care."We are thrilled to have GSK on board as we move to the next evolution of AGD," said Leeland Ekstrom, PhD, chief executive officer of NashBio. "There is proven value in the integration of proteomics and comprehensive datasets, evidenced by the boon of
More news about: Illumina, Inc.
Mar 05, 2026, 09:00 ET ulrich medical USA® Appoints Alissa Calaway, RN, MSN as Director of U.S. Clinical Affairs; Expands Commitment to Evidence-Based Spine Innovation
monitoring. "Expanding our clinical research efforts reflects our commitment to scientific rigor and partnership with the spine community," said Eric Lucas, PhD, Global Vice President of R&D, Spine for ulrich medical. "Clinical data helps us support surgeons and deliver technologies that improve patient outcomes
More news about: ulrich medical USA
Mar 05, 2026, 09:00 ET Vector Solutions Launches "Maximizing Your Education Experience" Microlearning Suite to Help Institutions Scale Student Success and Career Readiness
Community Engagement at The University of Mississippi."Preparing students to maximize their college experience is critical," said John "Jay" Ellison, PhD, Vice President for Student Success and the Roanoke Experience at Roanoke College. "By engaging students early, we can reduce summer melt, strengthen
More news about: Vector Solutions
Mar 05, 2026, 09:00 ET Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
rates with the potential to address a significant unmet need in patients who are refractory to frontline standard of care," said Lauren Baker Banks, MD, PhD, Sarcoma Medical Oncologist at Memorial Sloan Kettering Cancer Center. "Patients with UPS and DDLPS suffer from high disease burden, poor quality
More news about: Equity Insider
Mar 05, 2026, 08:16 ET New Data from National Sleep Foundation Show Nearly Half of U.S. Children Don't Get Enough Sleep
sleep."These findings reveal a gap between the sleep children need and what those closest to them say they actually get," said Joseph Dzierzewski, PhD, SVP of Research and Scientific Affairs, National Sleep Foundation. "When nearly half of U.S. children aren't getting the sleep they need, and at the
More news about: National Sleep Foundation
Mar 05, 2026, 08:00 ET Panome Bio Launches Exposomics Services to Measure the Chemical Drivers of Human Disease
for core services to offer the technology at the operational scale required for impactful findings in diverse human populations," said Gary J. Patti, PhD, Chief Scientific Officer of Panome Bio and Professor at Washington University in St. Louis. "I'm thrilled that Panome is opening up the field. I cannot
More news about: Panome Bio
Mar 05, 2026, 07:00 ET Hemab Therapeutics Receives FDA Breakthrough Therapy Designation for Sutacimig in Glanzmann Thrombasthenia
urgency of bringing new treatment options to people living with Glanzmann thrombasthenia who have been historically underserved," said Benny Sorensen, MD, PhD, Chief Executive Officer of Hemab. "We look forward to continued collaboration with the FDA, with the goal of bringing the first prophylactic treatment
More news about: Hemab Therapeutics
Mar 05, 2026, 07:00 ET NexCure, Inc. Launches with $19 Million Series A Financing to enable CAR-T and other advanced treatment delivery in community outpatient settings
surmount the operational barriers care providers face when attempting to provide access to these life-changing treatments," said Sophie Papa, FRCP, PhD, Founder and Chief Medical Officer at NexCure. "NexCure is helping to solve the challenge of bringing current and future complex therapies, with high
More news about: NexCure Inc.
Mar 05, 2026, 07:00 ET CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
[email protected] Investor Relations Contacts:Aman Patel, CFA & Adanna G. Alexander, PhDICR Healthcare [email protected]
More news about: Cytosorbents Corp
Mar 05, 2026, 02:24 ET New Publication: US clinicians' real-world Nevisense experience improves melanoma detection
Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, announced that Stephen D. Hess, MD, PhD, FAAD, has published a clinical article highlighting his real-world experience integrating Nevisense into routine melanoma detection. The article was
More news about: SciBase
Mar 04, 2026, 18:08 ET TECNO Advances Mobile Creativity and On-Device Generative AI at MWC 2026 with Arm Collaboration
compatibility across device tiers, and ultimately makes TECNO's already-advanced imaging technologies even more compelling and intuitive," said Minjie Chen, PhD, Head of Imaging Algorithms Department, TECNO.Real-Time, Split-Screen Preview at 30fpsTECNO undertook deep, low-level code construction
More news about: TECNO
Mar 04, 2026, 14:00 ET Southminster Launches Nation's First "Creative Aging on Prescription" Study with Major Research University and National Arts & Aging Experts
www.lifetimearts.org ADVISORSDr. Tasha Golden, Senior Research AdvisorTasha Golden, PhD is a singer/songwriter turned behavioral scientist, and a leading expert in the role of creativity in health and innovation. She speaks and consults
More news about: Southminster
Mar 04, 2026, 13:44 ET BrainXell Launches Human iPSC-Derived Sensory Neurons for Translational Neuroscience and Pain Biology Research
biology is highly complex, particularly when studying functional responses associated with pain signaling and ion channel activity," said Semra Sahin, PhD, Applications Scientist at BrainXell. "Our goal with this platform was to deliver a reproducible human model that combines strong molecular identity
More news about: BrainXell, Inc
Mar 04, 2026, 10:50 ET Kelsey H. Collins, PhD, Wins NEXT Award for Translational Research on Relationship between Fat and Osteoarthritis Development and Pain
career in research."Tracing How OA DevelopsSince beginning her PhD studies at the University of Calgary, Canada, under Walter Herzog, PhD, and continuing her postdoctoral work with Farshid Guilak, PhD, Dr. Collins focused her research on how adipose tissue (body fat) drives OA and pain.
More news about: American Academy of Orthopaedic Surgeons
Mar 04, 2026, 10:45 ET Johnny Huard, PhD, Receives the Arnold I. Caplan Award for Distinguished Research in Orthobiologics
ORLEANS, March 4, 2026 /PRNewswire/ -- The American Academy of Orthopaedic Surgeons (AAOS) announced Johnny Huard, PhD, as the recipient of the Arnold I. Caplan Award for Distinguished Research in Orthobiologics (Caplan Award). This prestigious recognition honors the
More news about: American Academy of Orthopaedic Surgeons
Mar 04, 2026, 10:30 ET ORBIT Award Presented to Robert L. LaPrade, MD, PhD, FAAOS, for 20 Years of Research to Advance Posterior Cruciate Ligament Injury Diagnosis, Treatment and Rehabilitation
/PRNewswire/ -- The 2026 Orthopaedic Research Bridging Innovation and Translation (ORBIT) Award was presented to principal investigator Robert F. LaPrade, MD, PhD, FAAOS and his research team for their foundational work to advance the diagnosis, surgical treatment and rehabilitation of
More news about: American Academy of Orthopaedic Surgeons
Mar 04, 2026, 09:00 ET CoVet's In-House Medical Team Shares AI Predictions for Veterinary Practices in 2026
running in the background of a veterinarian's day.Time and Confidence for Equine Practice: Dr. Adele Wiliams-Xavier, BVSc MRCVS DipECEIM PhD, predicts AI will give equine veterinarians their time and their confidence back by turning yard-side consults into clear, timely records with documentation
More news about: CoVet
Mar 04, 2026, 08:52 ET Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
Akeso's novel combination immunotherapy in the trial and welcome their efforts to help improve potential outcomes for patients."Yu (Michelle) Xia, PhD, founder, chairwoman, president, and Chief Executive Officer of Akeso, said, "We are truly excited to collaborate with INOVIO for the treatment of GBM.
More news about: Akeso, Inc.
Mar 04, 2026, 08:30 ET Combination Strategies To Improve Radioligand Therapy Efficacy, Upcoming Webinar Hosted by Xtalks
therapy combination strategies can improve efficacy through translational study design, imaging and safety-informed dosing.Join Julian Goggi, PhD, Director, Discovery Research,
More news about: Xtalks
Mar 04, 2026, 08:05 ET INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
outcomes and highlights our ongoing commitment to advancing innovative treatments for diseases with significant unmet need."Yu (Michelle) Xia, PhD, founder, chairwoman, president, and Chief Executive Officer of Akeso, said, "We are truly excited to collaborate with INOVIO for the treatment of GBM.
More news about: INOVIO Pharmaceuticals, Inc.